Hepatitis Market Research Reports & Industry Analysis
Hepatitis Industry Research & Market Reports
-
Global Hepatitis A Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. ... Read More
-
Global Hepatitis A Vaccine Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines ... Read More
-
Hepatitis A Vaccine Industry Research Report 2024
... HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ... Read More
-
Sexually Transmitted Diseases Diagnostics Market Size, Trends, Analysis, and Outlook By Disease (CT/NG, Gonorrhea, HIV/AIDS, Genital Herpes, Hepatitis B, Syphilis, Mycoplasma Genitalium, Genital Warts, Candidal Vaginitis, Trichomoniasis, Bacterial Vaginosis, HPV, Others), By Test (Culture/Isolation Of Organisms, Molecular Test, Immunology Assay, Others), By Device (Laboratory Devices, Point Of Care (Poc) Devices), By End-User (Laboratory, Point of Care (POC)), by Country, Segment, and Companies, 2024-2032
... Organisms, Molecular Test, Immunology Assay, Others), By Device (Laboratory Devices, Point Of Care (Poc) Devices), By End-User (Laboratory, Point of Care (POC)), by Country, Segment, and Companies, 2024-2032 The global Sexually Transmitted Diseases Diagnostics market ... Read More
-
Hepatitis C Market Size, Trends, Analysis, and Outlook By Diagnosis (Liver Biopsy, Blood Tests), By Treatment (Antiviral Drugs, Immune Modulator Drugs, Others), By End-User (Hospitals and Clinics, Diagnostic Laboratory, Others), by Country, Segment, and Companies, 2024-2032
... 2024-2032 The global Hepatitis C market size is poised to register 12.8% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Hepatitis C ... Read More
-
Strand Displacement Amplification Market Size, Trends, Analysis, and Outlook By Application (Tuberculosis, Hepatitis, Malaria, Influenza, Cancer, Others), By End-User (Hospitals, Diagnostic laboratories, Others), by Country, Segment, and Companies, 2024-2032
... size is poised to register 5.6% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Strand Displacement Amplification market across By Application (Tuberculosis, ... Read More
-
Infectious Disease Drugs Market Size, Trends, Analysis, and Outlook By Disease (HIV, Influenza, Hepatitis, Tuberculosis, Malaria, Others), By Treatment (Antibacterial, Antiviral, Antiparasitic, Others), by Country, Segment, and Companies, 2024-2032
... size is poised to register 7.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Infectious Disease Drugs market across By Disease (HIV, ... Read More
-
Serological Testing Market Size, Trends, Analysis, and Outlook By Technology (ELISA, NAT, CLIA/CMIA, Others), By Product (Instruments, Consumables and Reagents), By Application (Hepatitis, Coronavirus, Human Immunodeficiency Virus, Rotavirus infections, Others), By End-User (Diagnostic Laboratories, Hospitals, Others), by Country, Segment, and Companies, 2024-2032
... Others), by Country, Segment, and Companies, 2024-2032 The global Serological Testing market size is poised to register 8.1% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry ... Read More
-
Diagnostic Specialty Antibodies Market Size, Trends, Analysis, and Outlook By Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Polyclonal Antibodies), By Application (Hepatitis, Tuberculosis, Dengue, Oncology, HIV, Infectious Disease, Others), By End-User (Hospitals, Diagnostic Laboratories, Others), by Country, Segment, and Companies, 2024-2032
... Country, Segment, and Companies, 2024-2032 The global Diagnostic Specialty Antibodies market size is poised to register 4.9% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Global Immunodiagnostics Market Size Study & Forecast, by Product (Instruments, Reagents & Consumables), By Application (Oncology & Endocrinology, Hepatitis & Retrovirus, Cardiac Markers, Infectious Diseases, Others), By End user (Clinical Laboratories, Hospitals, Physician’s Offices, Others), and Regional Analysis, 2023-2030
... and Regional Analysis, 2023-2030 Global Immunodiagnostics Market is valued approximately at USD 17.83 billion in 2022 and is anticipated to grow with a growth rate of more than 7.30% over the forecast period 2023-2030. Immunodiagnostics ... Read More
-
Autoimmune Hepatitis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Chronic Hepatitis C Virus Infection - Pipeline Insight, 2024
... Infection pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the ... Read More
-
Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2024
... Delta Virus (HDV) Infection pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It ... Read More
-
Vaccines Market By Technology Type (Recombinant and Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Others), By Indication (Pneumococcal Disease, Influenza, Human Papilloma Virus, Meningococcal Disease, Rotavirus, Varicella, Measles, Mumps, and Rubella, Diphtheria, Pertussis, and Tetanus (DTP), Polio, Hepatitis, Other Indications), By End User (Pediatric, Adults, Travelers): Global Opportunity Analysis and Industry Forecast, 2024-2035
... and Tetanus (DTP), Polio, Hepatitis, Other Indications), By End User (Pediatric, Adults, Travelers): Global Opportunity Analysis and Industry Forecast, 2024-2035 The vaccine market was valued at $43.2 billion in 2023 and is projected to reach ... Read More
-
Chronic Hepatitis B Virus Infection - Pipeline Insight, 2024
... Infection pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the ... Read More
-
Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Growth 2024-2030
... US$ million in 2023. With growing demand in downstream market, the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % ... Read More
-
Hepatitis B Vaccines Market Size, Trends, Analysis, and Outlook By Type (Combination Vaccines, Single Antigen Hepatitis B Vaccines), By End-User (Hospitals, Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
... market size is poised to register 4.94% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Hepatitis B Vaccines market By Type ... Read More
-
Mono Vaccine Market Size, Trends, Analysis, and Outlook By Type (Meningococcal Vaccine, Japanese Encephalitis Vaccine, Hepatitis Vaccine, Yellow Fever Vaccine, Others), by Region, Country, Segment, and Companies, 2024-2030
... poised to register 5.59% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Mono Vaccine market By Type (Meningococcal Vaccine, Japanese Encephalitis ... Read More
-
Sexually Transmitted Diseases Treatment Market Size, Trends, Analysis, and Outlook By Disease (Gonorrhea, Syphilis, Herpes, Chlamydia, Hepatitis (HBV), Human Immunodeficiency Virus (HIV), Others), By Therapy (Anti-bacterial, Anti-viral, Vaccines, Anti-fungal), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Sexually Transmitted Diseases Treatment market size is poised to register 4.09% growth (CAGR) from 2024 to ... Read More
-
Hepatitis B Therapeutics Market Size, Trends, Analysis, and Outlook By Product (Anti-Virals, Hepatitis B Vaccine), By Therapy (Chemo Therapy, Immunosuppressant Therapy, Nucleoside Analogue), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Hepatitis B Therapeutics market size is poised to register 3.94% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Alcoholic Hepatitis Treatment Market Size, Trends, Analysis, and Outlook By Treatment (Drug, Stem Cell Therapy), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospitals, Stem Cell Centers, Specialized Clinics, Cancer Research Institutes, Retail Sales), by Region, Country, Segment, and Companies, 2024-2030
... by Region, Country, Segment, and Companies, 2024-2030 The global Alcoholic Hepatitis Treatment market size is poised to register 6.7% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. ... Read More
-
Travel Vaccines Market Size, Trends, Analysis, and Outlook By Disease (Influenza, Diptheria, Hepatitis, Typhoid, Others), By End-User (Adult vaccines, Pediatric vaccines), by Region, Country, Segment, and Companies, 2024-2030
... poised to register 9.79% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Travel Vaccines market By Disease (Influenza, Diptheria, Hepatitis, Typhoid, ... Read More
-
Liver Disease Treatment Market Size, Trends, Analysis, and Outlook By Treatment (Antiviral Drugs, Immunosuppressants, Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, Chemotherapy), By Disease (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030
... Region, Country, Segment, and Companies, 2024-2030 The global Liver Disease Treatment market size is poised to register 6.28% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Global Hepatitis B Treatment Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Hepatitis B Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global Prophylactic Hepatitis B Virus Vaccines Market Growth (Status and Outlook) 2024-2030
... 2023. With growing demand in downstream market, the Prophylactic Hepatitis B Virus Vaccines is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report ... Read More
Research Assistance
